Attached files
file | filename |
---|---|
8-K - FORM 8-K - ANADYS PHARMACEUTICALS INC | a56323e8vk.htm |
EX-1.1 - EX-1.1 - ANADYS PHARMACEUTICALS INC | a56323exv1w1.htm |
EX-99.2 - EX-99.2 - ANADYS PHARMACEUTICALS INC | a56323exv99w2.htm |
EX-99.1 - EX-99.1 - ANADYS PHARMACEUTICALS INC | a56323exv99w1.htm |
Exhibit 5.1
Steven M. Przesmicki
(858) 550-6070
przes@cooley.com
(858) 550-6070
przes@cooley.com
May 25, 2010
Anadys Pharmaceuticals, Inc.
5871 Oberlin Drive, Suite 200
San Diego, CA 92121
5871 Oberlin Drive, Suite 200
San Diego, CA 92121
Ladies and Gentlemen:
You have requested our opinion with respect to certain matters in connection with the offering by
Anadys Pharmaceuticals, Inc., a Delaware corporation (the Company), of 5,813,954 shares of the
Companys common stock, par value $0.001 (the Shares) pursuant to a Registration Statement on
Form S-3 (Registration Statement No. 333-158342) (the
Registration Statement), filed with the
Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended
(the Act), the prospectus dated April 23, 2009 (the Base Prospectus), and the prospectus
supplement dated May 25, 2010, filed with the Commission pursuant to Rule 424(b) of the Rules and
Regulations of the Act (the Prospectus Supplement). (The Base Prospectus and the Prospectus
Supplement are collectively referred to as the Prospectus.) The Shares are to be sold by the
Company as described in the Registration Statement and the Prospectus.
In connection with this opinion, we have examined and relied upon the Registration Statement, the
Prospectus, the Companys Amended and Restated Certificate of Incorporation, its Amended and
Restated Bylaws and the originals or copies certified to our satisfaction of such records,
documents, certificates, memoranda and other instruments as in our judgment are necessary or
appropriate to enable us to render the opinion expressed below. We have assumed the genuineness and
authenticity of all documents submitted to us as originals, and the conformity to originals of all
documents submitted to us as copies thereof and the due execution and delivery of all documents
where due execution and delivery are a prerequisite to the effectiveness thereof.
Our opinion herein is expressed solely with respect to the General Corporation Law of the State of
Delaware. Our opinion is based on these laws as in effect on the date hereof. We express no
opinion as to whether the laws of any particular jurisdiction are applicable to the subject matter
hereof.
On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when
sold in accordance with the Registration Statement and the Prospectus, will be validly issued,
fully paid and nonassessable.
4401 EASTGATE MALL, SAN DIEGO, CA 92121 T: (858) 550-6000 F: (858) 550-6420 WWW.COOLEY.COM
Anadys Pharmaceuticals, Inc.
Page Two
Page Two
We consent to the reference to our firm under the caption Legal Matters in the Prospectus and to
the filing of this opinion as an exhibit to the Registration Statement.
Very truly yours,
Cooley llp
By:
|
/s/ Steven M. Przesmicki
|
4401 EASTGATE MALL, SAN DIEGO, CA 92121 T: (858) 550-6000 F: (858) 550-6420 WWW.COOLEY.COM